Full Text View
Tabular View
No Study Results Posted
Related Studies
BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer
This study has been withdrawn prior to enrollment.
Study NCT01288092   Information provided by Novartis

First Received on January 19, 2011.   Last Updated on June 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial